FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Califf Nomination Heads to Senate HELP Hearing

[ Price : $8.95]

The Senate Health, Education, Labor & Pensions Committee announces a 12/14 hearing on the nomination of Robert Califf to be the ne...

FDA Inspections Will Adapt to New Strategies: Attorneys

[ Price : $8.95]

A Kleinfeld, Kaplan & Becker online post predicts that the prolonged Covid-19 pandemic will likely see the agency continue to adap...

2 Influencers Call for Using More RWD in Trials

[ Price : $8.95]

Two MedHealth influencers say the health community must find ways to expand the use of real-world data in clinical trials.

CBER Cell/Gene Therapy Office Swamped: Director

[ Price : $8.95]

CBER Office of Tissues and Advanced Therapies director Wilson Bryan says the office is swamped with new product submissions to the...

Hahn Leading Harbinger Health Testing Startup

[ Price : $8.95]

Former FDA commissioner Stephen Hahn is named CEO of Harbinger Health.

FDA Reviewers Doubt Reata Kidney Drugs Effectiveness

[ Price : $8.95]

Ahead of a 12/8 FDA advisory committee meeting, agency reviewers cast doubt on the effectiveness of Reata Pharmaceuticals bardoxol...

Theratechnologies sBLA for HIV Drug Administration

[ Price : $8.95]

Theratechnologies files a supplemental BLA for Trogarzo (ibalizumab-uiyk) and an intravenous push form of administration for treat...

Mammography Panel Seeks Nonvoting Reps

[ Price : $8.95]

Federal Register notice: FDA seeks industry organizations interested in participating in selecting nonvoting industry representati...

JAK Inhibitors Implement FDA Class Warning

[ Price : $8.95]

An FDA-ordered drug class warning begins appearing in labels of Janus kinase (JAK) inhibitors Pfizers Xeljanz (tofacitinib), Eli ...

RefleXion Breakthrough for Radiotherapy

[ Price : $8.95]

FDA grants RefleXion Medical a breakthrough device designation for its biology-guided radiotherapy for use in treating lung tumors...